Thalidomide in Treating Patients With Chronic Graft-Versus-Host Disease Following Bone Marrow Transplant

Clinical trial NCT00003894 · COMPLETED

Trial details

NCT number: NCT00003894
Sponsor: Roswell Park Cancer Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Graft Versus Host Disease Unspecified Adult Solid Tumor, Protocol Specific Unspecified Childhood Solid Tumor, Protocol Specific

Start date: 1999-03-01
Primary completion: 2000-01-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.